Tokyo - Delayed Quote JPY

KYORIN Pharmaceutical Co., Ltd. (4569.T)

Compare
1,428.00
+63.00
+(4.62%)
At close: 3:30:00 PM GMT+9
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
119,532,000
119,532,000
113,270,000
105,534,000
102,904,000
Cost of Revenue
68,124,000
68,124,000
63,102,000
56,093,000
51,276,000
Gross Profit
51,408,000
51,408,000
50,167,000
49,441,000
51,627,000
Operating Expense
45,394,000
45,394,000
45,043,000
44,433,000
45,841,000
Operating Income
6,014,000
6,014,000
5,124,000
5,008,000
5,786,000
Net Non Operating Interest Income Expense
-25,000
-25,000
-47,000
-64,000
-53,000
Pretax Income
7,019,000
7,019,000
6,906,000
5,216,000
8,352,000
Tax Provision
1,696,000
1,696,000
2,182,000
1,284,000
2,222,000
Net Income Common Stockholders
5,322,000
5,322,000
4,723,000
3,932,000
6,130,000
Diluted NI Available to Com Stockholders
5,322,000
5,322,000
4,723,000
3,932,000
6,130,000
Basic EPS
92.74
92.74
82.44
68.62
106.99
Diluted EPS
92.74
92.74
82.44
68.62
106.99
Basic Average Shares
57,389.38
57,389.38
57,303.07
57,301.98
57,295.92
Diluted Average Shares
57,448.79
57,389.38
57,303.07
57,301.98
57,295.92
Total Operating Income as Reported
6,013,000
6,013,000
5,123,000
5,007,000
5,786,000
Total Expenses
113,518,000
113,518,000
108,145,000
100,526,000
97,117,000
Net Income from Continuing & Discontinued Operation
5,322,000
5,322,000
4,723,000
3,932,000
6,130,000
Normalized Income
4,930,114
4,930,114
3,934,982.62
4,200,424
4,742,006
Interest Income
41,000
41,000
19,000
2,000
15,000
Interest Expense
66,000
66,000
66,000
66,000
68,000
Net Interest Income
-25,000
-25,000
-47,000
-64,000
-53,000
EBIT
7,085,000
7,085,000
6,972,000
5,282,000
8,420,000
EBITDA
11,375,000
11,375,000
10,812,000
8,996,000
11,984,000
Reconciled Cost of Revenue
68,124,000
68,124,000
63,102,000
56,093,000
51,276,000
Reconciled Depreciation
4,290,000
4,290,000
3,840,000
3,714,000
3,564,000
Net Income from Continuing Operation Net Minority Interest
5,322,000
5,322,000
4,723,000
3,932,000
6,130,000
Total Unusual Items Excluding Goodwill
517,000
517,000
1,152,000
-356,000
1,891,000
Total Unusual Items
517,000
517,000
1,152,000
-356,000
1,891,000
Normalized EBITDA
10,858,000
10,858,000
9,660,000
9,352,000
10,093,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
125,114
125,114
363,982.62
-87,576
503,006
3/31/2021 - 1/4/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade